These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1066 related items for PubMed ID: 23324230

  • 1. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
    Yao WK, Wang YP, Peng F, Zheng Y, Zou YB, Gao JN, Liu XL.
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma].
    Li M, Liu CL, Wang XY, Xue XM, Gao ZF.
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):813-7. PubMed ID: 23324229
    [Abstract] [Full Text] [Related]

  • 3. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
    Lin L, Min M, Bi CF, Wang XQ, Luo TY, Zhao S, Zhang WY, Liu WP.
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
    [Abstract] [Full Text] [Related]

  • 4. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP, Liu YH, Zhuang HG, Luo DL, Li L, Zhang F, Luo XL, Du X, Li WY, Chen Q.
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Primary lymphoma of breast: a clinicopathologic, immunophenotypic and prognostic study of 21 cases].
    Wang XQ, Zhang LX, Bi CF, Luo TY, Lin L, Min M, Zhao Y, He GX, Feng J, Liu WP.
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):302-7. PubMed ID: 20654152
    [Abstract] [Full Text] [Related]

  • 7. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY, Yong WB, Zhu J, Zheng W, Zhang YT, Wang XP, Meng SN.
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
    Wang C, Li W, Liu C, He H, Bai O.
    Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
    van Imhoff GW, Boerma EJ, van der Holt B, Schuuring E, Verdonck LF, Kluin-Nelemans HC, Kluin PM.
    J Clin Oncol; 2006 Sep 01; 24(25):4135-42. PubMed ID: 16943530
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases].
    Yang H, Lang RG, Liu FF, Wang XF, Jin ZJ, Lü AJ, Wang Y, Fu XL, Fu L.
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb 01; 40(2):79-84. PubMed ID: 21426801
    [Abstract] [Full Text] [Related]

  • 16. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH, Scott DW, Chhanabhai M, Berry B, Ruskova A, Berkahn L, Connors JM, Gascoyne RD.
    J Clin Oncol; 2011 Apr 10; 29(11):1452-7. PubMed ID: 21383296
    [Abstract] [Full Text] [Related]

  • 17. CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy.
    Hong J, Park S, Park J, Jang SJ, Ahn HK, Sym SJ, Cho EK, Shin DB, Lee JH.
    Ann Hematol; 2012 Dec 10; 91(12):1897-906. PubMed ID: 22864685
    [Abstract] [Full Text] [Related]

  • 18. [Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases].
    Yang YL, Wang J, Zhao LZ, Gao ZF, Jing HM, Ke XY.
    Ai Zheng; 2008 Jun 10; 27(6):636-41. PubMed ID: 18570740
    [Abstract] [Full Text] [Related]

  • 19. [Mechanism and clinical significance of anti-apoptotic gene bcl-2 expression in diffuse large B-cell lymphoma].
    Zeng LP, Wen YL, Ma Y, Wang GQ, Li Y, Wang J, Xu LL, Zhang XM.
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun 10; 40(6):377-81. PubMed ID: 21914345
    [Abstract] [Full Text] [Related]

  • 20. [Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
    Min M, Lin L, Bi CF, Wang XQ, Luo TY, Zhao S, Zhang WY, Liu WP.
    Zhonghua Zhong Liu Za Zhi; 2012 Feb 10; 34(2):110-6. PubMed ID: 22780928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.